Nafamostat mesilate attenuates postreperfusion syndrome during liver transplantation

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 977-983

  Ryu, H G ^a   Jung, C W ^a   Lee, C S ^a   Lee, J ^a  

^a Seoul National University Boramae Hospital   (South Korea)

Author keywords

Liver transplantation; reperfusion; serine protease inhibitor

Indexed keywords

NAFAMSTAT MESILATE; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE PERIOD; POSTREPERFUSION SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DOUBLE-BLIND METHOD; FEMALE; GUANIDINES; HUMANS; INFUSIONS, INTRAVENOUS; KALLIKREINS; KININS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLACEBOS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REPERFUSION; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; SYNDROME; TREATMENT OUTCOME; VASODILATION;

EID: 79955538679     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03514.x     Document Type: Article

References (26)

1. Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Pinsky MR,. Postreperfusion syndrome: Cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987; 19 (4 Suppl 3): 54-55. (Pubitemid 17132886)
2. Acosta F, Rodriguez MA, Sansano T, et al,. Influence of surgical technique on postreperfusion syndrome during liver transplantation. Transplant Proc 1999; 31: 2380-2381. (Pubitemid 29433962)
3. Ko JS, Kim GS, Gwak MS, et al,. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. Transplant Proc 2008; 40: 3308-3310.
4. Hilmi I, Horton CN, Planinsic RM, et al,. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008; 14: 504-508. (Pubitemid 351524406)
5. Ayanoglu HO, Ulukaya S, Tokat Y,. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc 2003; 35: 1442-1444. (Pubitemid 36765557)
6. Findlay JY, Kufner RP,. Aprotinin reduces vasoactive medication use during adult liver transplantation. J Clin Anesth 2003; 15: 19-23. (Pubitemid 36349108)
7. Jankowski CJ, Findlay JY, Plevak DJ,. Aprotinin and reduced epinephrine requirements in orthotopic liver transplantation. Anesthesiology 2002; 96: 254-255. (Pubitemid 34032513)
8. Milroy SJ, Cottam S, Tan KC, Hilmi I, Oyesola B,. Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. Br J Anaesth 1995; 75: 747-751.
9. Molenaar IQ, Begliomini B, Martinelli G, Putter H, Terpstra OT, Porte RJ,. Reduced need for vasopressors in patients receiving aprotinin during orthotopic liver transplantation. Anesthesiology 2001; 94: 433-438. (Pubitemid 32198450)
10. Fergusson DA, Hebert PC, Mazer CD, et al,. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331. (Pubitemid 351749156)
11. Gagne JJ, Griesdale DE, Schneeweiss S,. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: A meta-analysis of epidemiologic studies. Pharmacoepidemiol Drug Saf 2009; 18: 259-268.
12. Daniela K, Michael Z, Florian I, et al,. Influence of retrograde flushing via the caval vein on the post-reperfusion syndrome in liver transplantation. Clin Transplant 2004; 18: 638-641.
13. Gruttadauria S, Cintorino D, Musumeci A, et al,. Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation. Clin Transplant 2006; 20: 159-162.
14. Jugan E, Albaladejo P, Jayais P, Ecoffey C,. The failure of venovenous bypass to prevent graft liver postreperfusion syndrome. Transplantation 1992; 54: 81-84.
15. Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Jr,., Pinsky MR,. Postreperfusion syndrome: Hypotension after reperfusion of the transplanted liver. J Crit Care 1993; 8: 154-160. (Pubitemid 23275998)
16. Chemla D, Jayais P, Ecoffey C, Declere AD, Lecarpentier Y,. In vitro negative inotropic effect of plasma collected at the time of reperfusion in humans undergoing liver transplantation. Anesthesiology 1997; 87: 378-386. (Pubitemid 27435381)
17. Martin-Sanz P, Bosca L, Olmedilla L, et al,. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation. Clin Transplant 1999; 13: 221-230. (Pubitemid 29255778)
18. Tomasdottir H, Bengtson JP, Bengtsson A,. Neutrophil and macrophage activation and anaphylatoxin formation in orthotopic liver transplantation without the use of veno-venous bypass. Acta Anaesthesiol Scand 1996; 40: 250-255. (Pubitemid 26061965)
19. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A,. The kallikrein-kinin system: Current and future pharmacological targets. J Pharmacol Sci 2005; 99: 6-38. (Pubitemid 41366887)
20. MacGilchrist A, Craig KJ, Hayes PC, Cumming AD,. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. Clin Sci (Lond) 1994; 87: 329-335. (Pubitemid 24285276)
21. Okajima K, Uchiba M, Murakami K,. Nafamostat mesilate. Cardiovasc Drug Rev 1995; 13: 51-65.
22. Pâques EP, Römisch J,. Comparative study on the in vitro effectiveness of antithrombotic agents. Thromb Res 1991; 64: 11-21.
23. Iwama H, Nakane M, Ohmori S, et al,. Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol. Br J Anaesth 1998; 81: 963-964. (Pubitemid 28561334)
24. Nakane M, Iwama H,. A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate. Br J Anaesth 1999; 83: 397-404. (Pubitemid 29412692)
25. Higuchi N, Yamazaki H, Kikuchi H, Gejyo F,. Anaphylactoid reaction induced by a protease inhibitor, nafamostat mesilate, following nine administrations in a hemodialysis patient. Nephron 2000; 86: 400-401.
26. Paugam-Burtz C, Kavafyan J, Merckx P, et al,. Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors. Liver Transplant 2009; 15: 522-529.